Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Inflammatory Bowel Diseases

  Free Subscription


20.06.2022

1 AJR Am J Roentgenol
11 Aliment Pharmacol Ther
1 Dig Dis Sci
4 Dis Colon Rectum
1 Gut
4 Inflamm Bowel Dis
2 J Crohns Colitis
2 Lancet
1 PLoS One
1 Scand J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. ANUPINDI SA
    Editorial Comment: MRI-Based Assessment of Intestinal Motility in Children and Young Adults With Newly Diagnosed Crohn Disease Before and After Biologic Treatment.
    AJR Am J Roentgenol. 2022 Jun 15. doi: 10.2214/AJR.22.28020.
    PubMed        


    Aliment Pharmacol Ther

  2. QUINN KP, Busciglio IA, Burton DD, Inoue A, et al
    Letter: normalizing the ileoanal pouch-more than a one-step technique. Authors' reply.
    Aliment Pharmacol Ther. 2022;56:176-177.
    PubMed        

  3. WEST J, Card TR, Crooks CJ
    Editorial: seeing the light at the end of gastroscope - complications after elective procedures are ready for NICE, bright decision aid tools - authors' reply.
    Aliment Pharmacol Ther. 2022;56:157.
    PubMed        

  4. HADI Y, Kochhar GS
    Letter: paying attention to the comorbidities or extraintestinal complications in patients with inflammatory bowel disease during the COVID-19 pandemic-authors' reply.
    Aliment Pharmacol Ther. 2022;56:178.
    PubMed        

  5. LO SW, Garg M, Segal JP
    Letter: normalising the ileoanal pouch-more than a one-step technique.
    Aliment Pharmacol Ther. 2022;56:174-175.
    PubMed        

  6. BHURWAL A, Mutneja H, Seril D
    Editorial: COVID-19 vaccines are safe and effective in patients with inflammatory bowel disease-but many unanswered questions remain. Authors' reply.
    Aliment Pharmacol Ther. 2022;56:164-165.
    PubMed        

  7. BENCHIMOL EI, Kuenzig ME
    Editorial: COVID-19 vaccines are safe and effective in patients with inflammatory bowel disease-but many unanswered questions remain.
    Aliment Pharmacol Ther. 2022;56:162-163.
    PubMed        

  8. HADI Y, Kochhar GS
    Letter: the effect of anti-COVID-19 treatment on the outcome of patients with inflammatory bowel disease-authors' reply.
    Aliment Pharmacol Ther. 2022;56:179.
    PubMed        

  9. FEHILY SR, Al-Ani AH, Abdelmalak J, Rentch C, et al
    Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management.
    Aliment Pharmacol Ther. 2022;56:6-27.
    PubMed         Abstract available

  10. VAUGHAN R, Tjandra D, Patwardhan A, Mingos N, et al
    Toward transmural healing: Sonographic healing is associated with improved long-term outcomes in patients with Crohn's disease.
    Aliment Pharmacol Ther. 2022;56:84-94.
    PubMed         Abstract available

  11. LYONS M, Derikx LAAP, Fulforth J, McCall S, et al
    Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland: a retrospective prevalent cohort analysis.
    Aliment Pharmacol Ther. 2022;56:67-76.
    PubMed         Abstract available

  12. ROBLIN X, Veyrard P, Bastide L, Berger AE, et al
    Subcutaneous injection of infliximab CT-P13 results in stable drug levels within 14-day treatment cycle in Crohn's disease.
    Aliment Pharmacol Ther. 2022;56:77-83.
    PubMed         Abstract available


    Dig Dis Sci

  13. BARNES A, Ooi SJ, Lynch KD, Parthasarathy N, et al
    Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07556.
    PubMed         Abstract available


    Dis Colon Rectum

  14. KIM SW, Ho Park S, Hyoung Park S, Sik Yoon Y, et al
    Idiopathic Myointimal Hyperplasia of the Mesenteric Veins Is a Peculiar Venous Ischemia That May Be Diagnosed Before Surgery.
    Dis Colon Rectum. 2022;65:e707-e717.
    PubMed         Abstract available

  15. DURAES LC, Lee CHA, Holubar SD
    Use of Intraoperative Calibration Spheres for Endoluminal Stricture Assessment to Facilitate Heineke-Mikulicz Strictureplasty in Diffuse Stricturing Crohn's Jejunoileitis.
    Dis Colon Rectum. 2022;65:e741-e742.
    PubMed        

  16. AL KHALDI M, Richard C
    Diagnosis and Management of Idiopathic Pouchitis.
    Dis Colon Rectum. 2022;65:871-874.
    PubMed        

  17. CANNON LM
    Expert Commentary on Diagnosis and Management of Idiopathic Pouchitis.
    Dis Colon Rectum. 2022;65:874-875.
    PubMed        


    Gut

  18. DANESE S, Solitano V, Jairath V, Peyrin-Biroulet L, et al
    The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment).
    Gut. 2022 Jun 14. pii: gutjnl-2022-327025. doi: 10.1136/gutjnl-2022-327025.
    PubMed        


    Inflamm Bowel Dis

  19. JORDAN A, Maraj B, Kinnucan J
    Is it a Flare? Acute Appendicitis in Ulcerative Colitis Patient Found on Routine Screening Colonoscopy.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608386. doi: 10.1093.
    PubMed        

  20. LONG MD, Afzali A, Fischer M, Hudesman D, et al
    Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608417. doi: 10.1093.
    PubMed         Abstract available

  21. KAWAMOTO A, Fujii T, Mitani R, Suzuki Y, et al
    Serum Levels of Infliximab Biosimilar in a Child Delivered From a Mother Treated for Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608379. doi: 10.1093.
    PubMed        

  22. STAFFORD IS, Gosink MM, Mossotto E, Ennis S, et al
    A Systematic Review of Artificial Intelligence and Machine Learning Applications to Inflammatory Bowel Disease, with Practical Guidelines for Interpretation.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608231. doi: 10.1093.
    PubMed         Abstract available


    J Crohns Colitis

  23. ILVEMARK JFKF, Wilkens R, Thielsen P, Dige A, et al
    Early intestinal ultrasound predicts intravenous corticosteroid response in hospitalized patients with severe ulcerative colitis.
    J Crohns Colitis. 2022 Jun 13. pii: 6607631. doi: 10.1093.
    PubMed         Abstract available

  24. KIM KO, Kim EY, Lee YJ, Lee HS, et al
    Efficacy, safety and tolerability of oral sulfate tablet for bowel preparation in patients with inflammatory bowel disease: Multicenter randomized controlled study.
    J Crohns Colitis. 2022 Jun 11. pii: 6605993. doi: 10.1093.
    PubMed         Abstract available


    Lancet

  25. SANDS BE, Irving PM, Hoops T, Izanec JL, et al
    Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
    Lancet. 2022;399:2200-2211.
    PubMed         Abstract available

  26. CHAPMAN TP, Satsangi J
    Head-to-head biologic therapy in Crohn's disease.
    Lancet. 2022;399:2169-2171.
    PubMed        


    PLoS One

  27. HIGUCHI N, Hiraga H, Sasaki Y, Hiraga N, et al
    Automated evaluation of colon capsule endoscopic severity of ulcerative colitis using ResNet50.
    PLoS One. 2022;17:e0269728.
    PubMed         Abstract available


    Scand J Gastroenterol

  28. PUOLANNE AM, Qadri S, Vesterinen T, Hiltunen S, et al
    Can dysplasia surveillance be better targeted in ulcerative colitis by using faecal calprotectin?
    Scand J Gastroenterol. 2022 Jun 13:1-8. doi: 10.1080/00365521.2022.2084345.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: